Literature DB >> 6653863

The role of mitochondrial pyruvate transport in the control of lactate gluconeogenesis.

R Rognstad.   

Abstract

At low L-lactate concentrations, plots of the reciprocal of the gluconeogenic rate vs hydroxycyanocinnamate concentration were linear up to high inhibitor concentrations, indicating that the pyruvate transporter was a rate-limiting step and alternate pathways were at best minor. At 10 mM L-lactate and in the absence of added acids, the 1/V vs I plots became sigmoidal, indicating both some excess capacity of the transporter, and a significant alternative pathway. Use of transaminase inhibitors suggests that the alternate pathway does not primarily involve a dual glutamate-pyruvate transaminase mechanism.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6653863     DOI: 10.1016/0020-711x(83)90073-3

Source DB:  PubMed          Journal:  Int J Biochem        ISSN: 0020-711X


  10 in total

1.  A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans.

Authors:  Daniel K Bricker; Eric B Taylor; John C Schell; Thomas Orsak; Audrey Boutron; Yu-Chan Chen; James E Cox; Caleb M Cardon; Jonathan G Van Vranken; Noah Dephoure; Claire Redin; Sihem Boudina; Steven P Gygi; Michèle Brivet; Carl S Thummel; Jared Rutter
Journal:  Science       Date:  2012-05-24       Impact factor: 47.728

2.  Loss of Mitochondrial Pyruvate Carrier 2 in the Liver Leads to Defects in Gluconeogenesis and Compensation via Pyruvate-Alanine Cycling.

Authors:  Kyle S McCommis; Zhouji Chen; Xiaorong Fu; William G McDonald; Jerry R Colca; Rolf F Kletzien; Shawn C Burgess; Brian N Finck
Journal:  Cell Metab       Date:  2015-09-03       Impact factor: 27.287

Review 3.  Mitochondrial pyruvate transport: a historical perspective and future research directions.

Authors:  Kyle S McCommis; Brian N Finck
Journal:  Biochem J       Date:  2015-03-15       Impact factor: 3.857

4.  Marked secretion of pyruvate in human duodenal juice stimulated with pancreozymin or secretin.

Authors:  T Kuroshima; S Himeno; M Okuno; K Tsuji; H Kawamoto; Y Higashimoto; M Kashimura; Y Yamasaki; S Tarui
Journal:  Dig Dis Sci       Date:  1988-12       Impact factor: 3.199

5.  Glucagon up-regulates hepatic mitochondrial pyruvate carrier 1 through cAMP-responsive element-binding protein; inhibition of hepatic gluconeogenesis by ginsenoside Rb1.

Authors:  Meng-Die Lou; Jia Li; Yao Cheng; Na Xiao; Gaoxiang Ma; Ping Li; Baolin Liu; Qun Liu; Lian-Wen Qi
Journal:  Br J Pharmacol       Date:  2019-07-06       Impact factor: 8.739

6.  A re-evaluation of the role of mitochondrial pyruvate transport in the hormonal control of rat liver mitochondrial pyruvate metabolism.

Authors:  A P Halestrap; A E Armston
Journal:  Biochem J       Date:  1984-11-01       Impact factor: 3.857

7.  The involvement of pyruvate cycling in the metabolism of aspartate and glycerate by the perfused rat kidney.

Authors:  R C Scaduto; E J Davis
Journal:  Biochem J       Date:  1986-08-01       Impact factor: 3.857

8.  Partial reconstruction of in vitro gluconeogenesis arising from mitochondrial l-lactate uptake/metabolism and oxaloacetate export via novel L-lactate translocators.

Authors:  Lidia De Bari; Anna Atlante; Daniela Valenti; Salvatore Passarella
Journal:  Biochem J       Date:  2004-05-15       Impact factor: 3.857

9.  Mitochondrial pyruvate carrier 2 hypomorphism in mice leads to defects in glucose-stimulated insulin secretion.

Authors:  Patrick A Vigueira; Kyle S McCommis; George G Schweitzer; Maria S Remedi; Kari T Chambers; Xiaorong Fu; William G McDonald; Serena L Cole; Jerry R Colca; Rolf F Kletzien; Shawn C Burgess; Brian N Finck
Journal:  Cell Rep       Date:  2014-06-05       Impact factor: 9.423

10.  The mitochondrial pyruvate carrier mediates high fat diet-induced increases in hepatic TCA cycle capacity.

Authors:  Adam J Rauckhorst; Lawrence R Gray; Ryan D Sheldon; Xiaorong Fu; Alvin D Pewa; Charlotte R Feddersen; Adam J Dupuy; Katherine N Gibson-Corley; James E Cox; Shawn C Burgess; Eric B Taylor
Journal:  Mol Metab       Date:  2017-09-18       Impact factor: 7.422

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.